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Abstract  
Objectives 
In the recent TRUFFLE study it appeared that, in pregnancies complicated by fetal growth 
restriction (FGR) between 26 and 32 weeks, monitoring of the ductus venosus (DV) combined 
with computerised cardiotocography (cCTG) as a trigger for delivery, increased the chance of 
infant survival without neurological impairment. However, concerns in interpretation were raised 
as DV monitoring appeared associated with a non-significant increase in fetal death, and part of 
the infants were delivered after 32 weeks, after which the study protocol was no longer applied. 
This secondary sensitivity analysis focuses on women who delivered before 32 completed weeks, 
and analyses fetal death cases in detail. 
Methods 
We analysed the monitoring data of 317 women who delivered before 32 weeks, excluding 
women with absent infant outcome data or inevitable perinatal death. The association of the last 
monitoring data before delivery and infant outcome was assessed by multivariable analysis. 
Results 
The primary outcome (two year survival without neurological impairment) occurred more often in 
the two DV groups (both 83%) than in the CTG-STV group (77%), however the difference was not 
statistically significant (p=0.21). Nevertheless, in surviving infants 93% was free of neurological 
impairment in the DV groups versus 85% in the CTG-STV group (p=0.049). All fetal deaths (n=7) 
occurred in women allocated to DV monitoring, which explains this difference. Assessment of the 
monitoring parameters that were obtained shortly before fetal death in these 7 cases showed an 
abnormal CTG in only one.  
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Multivariable regression analysis of factors at study entry demonstrated that higher gestational 
age, larger estimated fetal weight 50th percentile ratio and lower U/C ratio were significantly 
associated with the (normal) primary outcome. Allocation to the DV groups had a smaller effect, 
but remained in the model (p<0.1). Assessment of the last monitoring data before delivery showed 
that in the CTG-STV group abnormal fetal arterial Doppler was significantly associated with 
adverse outcome. In contrast, in the DV groups an abnormal DV was the only fetal monitoring 
parameter that was associated with adverse infant outcome, while fetal arterial Doppler, STV 
below CTG-group cut-off or recurrent fetal heart rate decelerations were not. 
 
 
Conclusions 
In accordance with the results of the overall TRUFFLE study of the monitoring-intervention 
management of very early severe FGR we found that the difference in the proportion of infants 
surviving without neuroimpairment (the primary endpoint) was non-significant when comparing 
timing of delivery with or without changes in the DV waveform. However, the uneven distribution of 
fetal deaths towards the DV groups was likely by chance, and among surviving children 
neurological outcomes were better. Before 32 weeks, delaying delivery until abnormalities in DVPI 
or STV and/or recurrent decelerations occur, as defined by the study protocol, is therefore 
probably safe and possibly benefits long-term outcome. 
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Introduction and objective 
No cure exists for fetal growth restriction (FGR). Only timely diagnosis, fetal surveillance and the 
decision to deliver the baby when fetal condition deteriorates can reduce the risk of mortality and 
neurological impairments. No consensus exists as to the best way of monitoring and triggering 
delivery in early preterm FGR, although optimal timing of delivery could be crucial for the chance 
of healthy survival.  
The TRUFFLE study, carried out in 20 European perinatal centres, explored if a monitoring 
method that uses abnormal ductus venosus (DV) measurements (‘early’ at 95th percentile or ‘late’ 
at absent A-wave) or abnormal findings of computerised cardiotocography (cCTG) as a trigger for 
delivery, could increase the chance of healthy infant survival compared to the standard monitoring 
method by cCTG in pregnancies complicated by FGR between 26 and 32 weeks.(1, 2) Survival 
without neurological impairment occurred more often in the group using late ductus and cCTG 
changes as trigger for delivery compared to the cCTG group, while differences between the early 
and late DV group were minimal.(2) However, reservations in data interpretation were raised by 
the fact that only a proportion of the fetuses allocated to delivery based on ductus venosus 
changes actually delivered according to this criterion, the majority having been delivered on 
cardiotocography safety net criteria. Also, all fetal deaths were in the DV groups. Differences in 
outcome between the DV groups were minimal and part of the infants were delivered after 32 
weeks, the term after which the study protocol was no longer followed. This sensitivity analysis 
aims to focus on women delivered according to the formal protocol, thus restricted to women who 
delivered before 32 completed weeks, to pinpoint the effect of ductus venosus added to CTG in 
the monitoring of growth-restricted fetuses. The second aim is to analyse the monitoring data in 
the fetal deaths. 
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Methods 
The study design has been described earlier.(1, 2) In short, women with singleton fetuses at 26-32 
weeks of gestation, with abdominal circumference <10th percentile and umbilical artery Doppler 
pulsatility index (PI) >95th percentile, were included in a twenty centre European study (ISRCTN 
56204499). Baseline maternal and fetal data were collected via a secure internet data entry page. 
Study group allocation was performed in an even ratio from randomly sized blocks, stratified for 
gestational age (lower or higher than 29 weeks of gestation) and for participating centres. Eligible 
women were allocated for delivery according to one of three monitoring arms: reduced 
cardiotocography (cCTG) fetal heart rate short-term variation (STV<3.5 ms at a gestational age 
below 29 weeks and <4.0 ms thereafter), early ductus venosus (PI>95th percentile; ‘DV p95’) or 
late ductus venosus changes (‘a’ wave at or below baseline; ‘DV no A’). Abnormal DV 
measurements should be repeated within 24 hours, if cCTG results allowed this, to demonstrate 
consistency. In all groups delivery could also be decided on ‘safety net criteria’ when the cCTG 
showed recurrent decelerations, or in the DV groups when STV was very low (STV<2.6 ms at a 
gestational age below 29 weeks and <3.0 ms thereafter).  
The primary outcome was survival without cerebral palsy, severe neurosensory impairment or low 
Bayley Scales of Infant Developmental score <85 at 2 years of age.  
This post-hoc analysis targets at the association of fetal monitoring data (CTG STV, DV PI, DV a-
wave, umbilical artery PI, middle cerebral artery PI and the umbilical artery / middle cerebral artery 
ratio (UC ratio), that were available shortly before delivery, and outcome (two years 
neurodevelopmental outcome, fetal, neonatal, infant death). 
Because the study protocol was restricted to management before 32 weeks and monitoring data 
thereafter were not stored (and DV was not used), we analysed the data of women who delivered 
before 32 weeks only. Seven women with inevitable fetal or neonatal death, and one with absent 
neonatal data, who had remained in the primary published intention to treat analysis, were 
excluded in this analysis as these circumstances precluded any exploration of the association 
between monitoring data and outcome. In five of these women fetal death occurred due to refusal 
of intervention, and in two the babies died shortly after delivery because of lethal congenital This article is protected by copyright. All rights reserved.
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abnormality (one trisomy 18, one complex cardiac defect). In one no neonatal data could be 
provided after neonatal transfer immediately after delivery. Furthermore short-term data of 33 
surviving infants (9%), who could not be examined after two years, were excluded from endpoint 
data analysis.  
 
Cut-off values for fetal monitoring data were as defined by the study protocol. For reference of 
estimated fetal weight and birth weight a ratio was calculated with a 50th percentile (p50) weight 
adjusted for gestational age, maternal ethnic descent, weight and length and infant sex.(3) 
The effect of the most recent monitoring registration before birth on long-term outcome was 
evaluated by univariable and multivariable analysis. Univariable analysis used Anova, Chi-square 
or Kruskal-Wallis as appropriate. Multivariable analysis allowed the adjustment for relevant clinical 
details that were significantly different between outcome categories in univariable analysis. Criteria 
for inclusion and exclusion of potential variables were set at 0.05 and 0.10 respectively. IBM SPSS 
version 22 (New York, USA) was used for statistics.  
Results 
Three-hundred and seventeen (of the original 503) FGR infants with known outcome (either with 
perinatal death or follow-up examination at 2 years) were delivered before 32 weeks and included 
in this post-hoc analysis (Table 1). For the purposes of further analysis the two DV groups were 
combined to assess more precisely the association of abnormal DV PI with infant outcome. The 
primary outcome (two-year survival without neurological impairment) occurred more often in the 
DV groups (both 83%) than in the CTG-STV group (77%), although this difference is not 
statistically significant (p=0.21). Nevertheless, when analysing the group of surviving infants, the 
prevalence of neurological impairment in the DV groups was half of the prevalence in the CTG 
groups (14/190 (7%) versus 14/95 (15%); RR 0.50 (0.25 to 1.00); p=0.049, numbers-needed-to-
treat [NNT] 13).  
 
Table 2A and 2B demonstrate demographic, obstetric and neonatal information specified for 
normal or abnormal neurological infant development at the corrected age of 2 years, and perinatal This article is protected by copyright. All rights reserved.
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mortality. Thirty-two infants (10%) had died (7 antenatal, 25 neonatal). Causes for neonatal death 
that were not included in the study definition of severe neonatal morbidity were acute respiratory 
distress, multi-organ failure or clinical sepsis. Twenty-eight infants (9%) had impaired neurological 
development at two years corrected age.  
Women with a normal infant outcome had been randomised at a higher gestational age and the 
estimated fetal weight and birthweight p50 ratio were larger than in women with an infant who died 
or had abnormal development. All fetal deaths (n=7) occurred in women allocated to DV 
monitoring. Assessment of the monitoring parameters obtained shortly before fetal death showed 
that in only one case STV was below the CTG group cut-off, whereas DV was still normal (Table 
3). All other fetal death cases had either no STV assessment within 24 hours before fetal death or 
a normal CTG according to CTG-group protocol. In two cases the most recent DV PI before death 
had been higher than 95th percentile (but these cases had been allocated to the DV no A group). 
At delivery, infants with a normal outcome were born at later gestational age, with a higher birth 
weight and birth weight ratio, and less frequently had a low APGAR score. At discharge, severe 
composite morbidity was less likely in infants with a normal outcome (definition of composite 
morbidity and results given in Table 2b). Especially cerebral haemorrhage and periventricular 
leucomalacia (PVL) were more frequent in infants with an abnormal outcome (17%) than in the 
normal outcome group (2%). Eighty-three percent of the live-born infants survived without 
neurological impairment, although 28% of these infants had severe morbidity in the neonatal 
period. In contrast, thirteen of the 28 infants (46%) with neurological impairment did not have 
severe morbidity during the neonatal period.  
There were no differences in inclusion characteristics, or in obstetric and neonatal details between 
the randomisation groups and between infants with or infants without follow-up at two years age 
corrected for prematurity (data published previously(2)). Infants delivered after 32 weeks were 
included at a later gestational age, and a larger estimated fetal weight and had better outcomes 
than those included earlier, as can be expected.  
Multivariable regression analysis of factors at study entry demonstrated that gestational 
hypertension, larger estimated fetal weight p50 ratio and lower U/C ratio were significantly This article is protected by copyright. All rights reserved.
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associated with the (normal) primary outcome (Figure 1A). Allocation to the DV groups had a 
smaller effect, but remained in the model (p<0.1). Multivariable analysis with parameters known at 
delivery demonstrated that women with a normal outcome were more likely to have been allocated 
to the DV-groups, had a lower U/C ratio, and their babies had a higher birth weight, a higher 
APGAR score and were more often female (Figure 1B). If this analysis was repeated including DV 
PI only in those women who had a last DV measurement within 3 days of delivery or fetal death 
(n=180) then only a last DV measurement higher than 95th percentile was negatively associated 
with the primary endpoint and a larger birth weight p50 ratio had a positive effect, while the other 
parameters were ejected from the model (Figure 1C). 
The association between the last fetal monitoring before birth (or fetal death) and primary outcome 
is specified in greater detail in Table 4 separately for participants of the CTG-STV group and the 
DV groups. There appeared a difference of the impact of abnormal monitoring results on the 
primary outcome between these groups. In the CTG group, umbilical artery Doppler ARED flow 
and high U/C-ratio were negatively associated with the primary outcome (Figure 2A). In the DV 
groups an abnormal DV PI > 95th percentile was negatively associated with the primary outcome 
and this effect was more pronounced after recurrent elevated DV PI > 95th percentile with a longer 
interval than 1 day (which was allowed by the study protocol) (Figure 2B). The negative effect of 
an abnormal DV PI >95th percentile was not further affected by a combination with a STV below 
CTG-STV group cut-off, below DV safety-net cut-off or decelerations. Although the U/C ratio in the 
DV groups was of the same value as in the CTG group and the incidence of umbilical artery ARED 
flow was similar, the negative association of these parameters with the primary endpoint that was 
observed in the CTG-STV group was absent in the DV groups. 
 
Discussion  
This secondary sensitivity analysis of TRUFFLE strengthens the conclusion of the primary 
intention-to-treat analysis, that perinatal outcomes are improved if ductus venosus measurements 
are added to CTG-STV in the monitoring of fetuses with severe early-onset FGR. The analysis 
targeted those infants that were delivered before 32 weeks to focus on the effect of the different 
This article is protected by copyright. All rights reserved.
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monitoring techniques and looked in-depth at the perinatal deaths and the association between 
the most recent fetal monitoring parameters with the primary outcome. 
 
In this post-hoc analysis both DV groups were combined because we wanted to explore the 
association of 2-year infant outcome with DV measurement results. It was deemed justified 
because survival with normal neurodevelopment at 2 years corrected for prematurity was equal in 
both DV groups (both 83% in infants with known outcome). Normal 2 year outcome was less 
frequent in the CTG-STV group (77%), but this difference was not statistically significant.  
Perinatal mortality was similar between the CTG-STV and the DV groups (10%), however all 
antenatal deaths (n=7) occurred in the DV groups. Analysis of this antenatal mortality suggested 
this was a spurious result: 6 of 7 cases would probably also not have been delivered timely if they 
had been allocated to the CTG-STV group as the last STV results were above the CTG-group cut-
off limits. Two cases of fetal death might have benefited from a DVPI cut-off at the 95th percentile 
instead of absent a-wave.  
 
Multivariable analysis did not demonstrate a significant benefit for normal primary outcome in 
those randomised to the DV groups after adjustment for gestational age and fetal weight p50 ratio. 
If the analysis is restricted to those that are born alive, assuming that fetal death had occurred 
unbalanced by chance, there is a statistically significant benefit for DV monitoring. This is in line 
with aggregated cohort evidence as systematically reviewed by Morris et al.(4) who showed 
moderate predictive accuracy of longitudinal DV measurements for fetal/neonatal wellbeing in 
high-risk pregnancies (likelihood ratio 3.15; 95% CI 2.19-4.54).   
Analysis of the results of the different monitoring techniques shows that with CTG monitoring 
decelerations and umbilical artery ARED flow are negatively associated with outcome while this is 
not so with combined DV and CTG monitoring. It might be that those at risk for neurological 
impairment with ARED flow are delivered more timely in the DV groups because of abnormal DV 
measurement, although we cannot prove this because DV was not measured in the CTG-STV 
group after inclusion.  This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
Typically, umbilical artery / middle cerebral artery flow abnormalities precede abnormalities of DV 
flow pattern.(5, 6) Elevated U/C ratio and umbilical artery ARED flow are known predictors of 
adverse outcome in pregnancies with FGR.(7) Our findings confirmed this but only in the CTG-
STV group.  
Possibly, Doppler assessment of ductus venosus allowed ’fine tuning’ of the timing of delivery, and 
selection of a sub-group of fetuses with severe redistribution (U/C ratio) and severe placental 
impairment (umbilical ARED flow) who were most at risk for cerebral damage. 
 
The observation that elevated DV PI or absent / reversed a-wave is associated with increased 
neonatal morbidity and adverse long-term infant outcome and that DV flow abnormalities are a 
stronger predictor of these outcomes than umbilical artery flow abnormalities have been described 
earlier.(8, 9) The current analysis, where in the DV groups abnormal DV flow pattern is associated 
with abnormal neurological outcome is consistent with these observations.  
 
The difference in association between monitoring data and outcome between the CTG-STV group 
and the DV groups, and the lower prevalence of neurological impairment in survivors in the DV 
groups, may support the hypothesis that in some early preterm growth restricted infants cardiac 
dysfunction (abnormal DV assessment) can precede cerebral dysfunction (low CTG-STV). Thus, 
timely detection of these changes by DV measurement (and subsequent action) can prevent 
neurological impairment in some fetuses. In others this sequence can be opposite with earlier STV 
abnormality or recurrent heart rate decelerations as indication for delivery. In four cases with fetal 
death the most recent DV was in the normal range, but in two it was higher than the 95th 
percentile. Frauenschuh et al. found that in 4 cases of severe placental insufficiency ductus 
venosus blood flow prior to intrauterine fetal death can be unaffected.(10) Thus it is well possible 
that there is some variation in the effect of malnutrition and hypoxia on the FGR fetus and the 
onset of organ damage may not follow the same pattern in all fetuses. 
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We only included babies delivered before 32 weeks because by protocol and in practice, ductus 
venosus Doppler only contributed to the delivery decision before 32 weeks gestation. The potential 
bias introduced by excluding differential delivery after 32 weeks by trial allocation group is likely to 
be small, since the post 32 week numbers were equally distributed between the groups. Results 
from this analysis can therefore only be applied to women with FGR before 32 weeks. 
 
This post-hoc analysis highlights some of the effects of DV-monitoring that were obscured by the 
original intention-to-treat analysis. However, just like all post-hoc analyses there should be caution 
regarding the possibility of bias. Nonetheless, the current findings are consistent with the original 
data.  
 
 
Conclusions 
In accordance with the results of the overall TRUFFLE study of the monitoring-intervention 
management of very early severe FGR we found that the difference in the proportion of infants 
surviving without neuroimpairment (the primary endpoint) was non-significant when comparing 
timing of delivery with or without changes in the DV waveform. However, we speculate that the 
uneven distribution of fetal deaths towards the DV groups was likely by chance, and we found that 
among surviving children the neurological outcomes at two years of age were better. Adverse 
neurodevelopmental outcome was significantly associated with abnormal DVPI before delivery 
and lower birth weight in surviving babies. Before 32 weeks, delaying delivery until abnormalities 
in DVPI or STV and/or recurrent decelerations occur, as defined by the study protocol, is therefore 
probably safe and possibly benefits long-term outcome. 
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Table 1  
Randomisation allocation, with selection for post-hoc analysis and primary study outcome. 
 CTG-STV DV p95 DV noA Total 
Total study group (row%) 166 (33%) 
167 
(33%) 
170 
(34%) 503 
Excluded Inevitable perinatal death  2 1 4 7 
  Neonatal data missing 1 -- -- 1 
  Alive, but no follow-up at 2 
years 21 (13%) 25 (15%) 13 (8%) 59 (12%) 
  Delivered at 32 weeks or  later 37 (22%) 39 (23%) 43 (25%) 119 (24%)
Delivered before 32 weeks 105 (63%) 
102 
(61%) 
110 
(65%) 317 (63%)
 Gestational age (median (IQR)) 
29.7 
(28.5 to 
30.9) 
29.9 
(28.7 to 
30.9) 
29.9 
(28.7 to 
30.7) 
29.9 (28.6 
to 30.9) 
 Birthweight (mean (SD)) 888 (202) 
887 
(220) 
876 
(208) 884 (209) 
 Fetal death 0 (--) 3 (3%) 4 (4%) 7 (2%) 
 Neonatal death 10 (10%) 6 (6%) 9 (8%) 25 (8%) 
 Alive and evaluated at 2 years 95  (90%) 93 (91%) 97 (88%) 285 (90%)
 Alive without neurological impairment  
 % of evaluated live infants (p=0.049)* 
 % of all infants with known outcome 
(p=0.21)* 
81  
(85%) 
(77%) 
85  
(91%) 
(83%) 
91  
(94%) 
(83%) 
257 
(90%) 
(81%) 
*Pearson’s chi-square for comparison of the CTG-STV group with both DV groups combined 
This article is protected by copyright. All rights reserved.
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Table 2a.  
Demographic and obstetric characteristics at study entry, specified for study primary outcome for 
all infants with known outcome (omitting 33 lost to follow-up) – percentages for each row. 
 Normal Impaired Dead All known outcome 
Delivered <32 weeks  
(row%) 257 (81%) 28 (9%) 32 (10%) 317 
Maternal age 31 (5) 31 (5) 30 (5) 31 (5) 
Caucasian ethnicity 220 (86%) 25 (89%) 29 (91%) 274 (86%) 
Nulliparity * 159 (62%) 14 (50%) 27 (84%) 200 (63%) 
BMI (kg/m2) 25 (6) 25 (6) 25 (5) 25 (6) 
Smoking 30 (12%) 6 (21%) 4 (13%) 40 (13%) 
GA (w+d) * 
28+6  
(26+0 to 
31+5) 
28+1  
(26+0 to 
31+0) 
27+6  
(26+0 to 
31+4) 
28+4  
(26+0 to 
31+5) 
EFW (g) * 852 (193) 778 (180) 703 (178) 833 (202) 
EFW p50 ratio * 0.65 (0.09) 0.62 (0.08) 0.60 (0.08) 0.64 (0.09) 
Uterine artery notch  131 (51%) 19 (68%) 20 (63%) 170 (54%) 
UA PI  2.0 (0.5) 2.2 (0.7) 2.2 (0.7) 2.1 (0.6) 
UA ARED flow 111 (43%) 15 (54%) 18 (56%) 144 (45%) 
UA RED flow 15 (6%) 1 (4%) 3 (9%) 19 (6%) 
U/C ratio*  1.5 (0.5) 1.8 (0.6) 1.7 (0.8) 1.5 (0.6) 
* between groups p < 0.05;  
Abbreviations: BMI = body mass index; GA = gestational age; EFW = estimated fetal weight; p50 
= 50th percentile; UA = umbilical artery; PI = pulsatility index; AREDflow = absent/reversed end-
diastolic flow; U/C-ratio = umbilical artery / middle cerebral artery PI ratio; 
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Table 2b 
Obstetric data after inclusion and neonatal data, specified for study primary outcome for all infants 
with known outcome 
 Normal Impaired Dead All known outcome 
All (row%) 257 (81%) 28 (9%) 32 (10%) 317 
Any hypertensive morbidity 203 (79%) 22 (79%) 23 (72%) 248 (78%) 
Preeclampsia-HELLP  155 (60%) 15 (54%) 16 (40%) 286 (59%) 
Antihypertensive medication 162 (63%) 16 (57%) 16 (50%) 194 (61%) 
Magnesium treatment * 63 (25%) 3 (11%) 3 (9%) 69 (22%) 
Interval to delivery (days) 7 (6) 8 (7) 6 (6) 7 (7) 
GA (w+d)  * 
30+0  
(26+2 to 
31+6) 
29+5  
(26+1 to 
31+3) 
28+5  
(26+1 to 
31+6) 
29+6  
(26+1 to 
31+6) 
Fetal death -- -- 7 (22%) 7 (2%) 
Live-born (row%) 257 (83%) 28 (9%) 25 (8%) 310 
Birth weight (g) * 910 (203) 804 (170) 736 (231) 887 (209) 
Birth weight p50 ratio * 0.59 (0.09) 0.54 (0.07) 0.55 (0.10) 0.59 (0.09) 
Male sex * 118 (46%) 20 (71%) 12 (48%) 150 (48%) 
Apgar score <7 * 29 (11%) 9 (32%) 6 (24%) 44 (14%) 
UA pH (n=280) 7.3 (6.8 to 7.4) 
7.3 (7.0 to 
7.4) 
7.3 (6.9 to 
7.3) 
7.3 (6.8 to 
7.4) 
UA pH <7.0 2 (1%) 1 (5%) 1 (5%) 4 (1%) 
Composite severe morbidity † * 73 (28%) 15 (54%) 16 (64%) 104 (34%) 
   BPD * 32 (13%) 8 (29%) 2 (8%) 42 (14%) 
   Sepsis (Proven) * 43 (17%) 7 (25%) 12 (48%) 62 (20%) 
   NEC * 6 (3%) 0 (--) 5 (20%) 11 (4%) 
   GMH Grade III or IV  * 4 (2%) 4 (14%) 3 (12%) 11 (4%) 
   PVL Grade II or III 2 (1%) 2 (7%) 0 (--) 4 (1%) 
* between groups p < 0.05 
* row% = the percentage of the row (horizontal) total 
 
†Components of severe morbidity: BPD (supplemental oxygen at 36 weeks gestational age), GMH 
grade III or IV, PVL grade II or III, NEC (diagnosed by X-ray or laparotomy) or proven sepsis. 
Abbreviations: CTG = cardiotocography; STV = short-term variation; DV = ductus venosus; BMI = 
body mass index; GA = gestational age;  p50 = 50th percentile; EFW = estimated fetal weight; UA 
= umbilical artery; MCA = middle cerebral artery; PI = pulsatility index; AREDflow = 
absent/reversed end-diastolic flow; U/C-ratio = umbilical artery / middle cerebral artery PI ratio; 
HELLP = hemolysis elevated liver enzymes low platelets; BPD = bronchopulmonary dysplasia; 
GMH = germinal matrix haemorrhage; PVL = periventricular leucomalacia; NEC = necrotizing 
enterocolitis; 
[Authors would prefer to combine join table 2a and 2b, but this may not improve clarity] 
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Table 3. 
Characteristics of the seven cases of fetal death. Last CTG registered < 24 hours before death, 
last DV registered within 3 days before death, last umbilical Doppler within 1 week before death 
Cas
e 
Allocatio
n 
GA 
at 
birth 
Last 
CTG 
< 24 
hrs 
Last 
STV 
Las
t 
ST
V 
low 
Las
t 
CT
G 
dec
el 
Last  
DV 
PI 
Last 
DV 
high 
Last 
DV a-
wave 
Last 
PI 
UA 
Last 
U/C 
Last 
EDF 
Comment 
1 DV no A 29 Yes 5,1 No No ,30 No prese
nt 
1,6 1,2 presen
t 
 
2 DV p95 29 Yes 2,7 Ye
s 
No ,57 No prese
nt 
3,8 3,5 absent  
3 DV no A 28 Yes 5,2 No No 1,01 >p9
5 
prese
nt 
2,2 1,5 absent  
4 DV p95 27 No 6,9 No No ,77 No prese
nt 
1,9 1,3 absent Abruptio 
plac. 
5 DV p95 29 No 7,5 No No ,66 No prese
nt 
4,8 5,4 revers
ed 
 
6 DV no A 27 Yes 5,6 No No 1,10 >p9
5 
prese
nt 
1,6 1,3 presen
t 
 
7 DV no A 28 Yes 5,8 No No ,74 No prese
nt 
2.0 1,7 presen
t 
 
Abbreviations: GA = gestational age; CTG = cardiotocography; STV = short-term variation; DV = 
ductus venosus; UA = umbilical artery; PI = pulsatility index; EDF = end-diastolic flow; U/C-ratio = 
umbilical/cerebral ratio;  
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Table 4. 
Last results of fetal monitoring before delivery or fetal death, for participants allocated to the CTG-
STV group or to either of the DV groups. The latter groups have been combined. Participants are 
included in the table if the last CTG was within 24 hours, the last DV within 3 days or the last fetal 
arterial Doppler within 1 week of delivery or fetal death. Percentages are calculated from column 
totals. Numbers add up to more than 100 because many foetuses had multiple test results 
recorded within the relevant time period.    
8 cases from STV group and 8 cases from DV groups excluded because they had no last CTG < 
24 hours before birth. 20 cases from DV groups excluded because they had no last DV PI within 3 
days before delivery. 
Group allocation Normal 
neuro 
dev. 
 
Abnorma
l neuro 
dev 
 
Neonatal 
death 
 
Fetal 
death 
 
Total 
 
 
CTG  N with last STV<24 hrs 78  13  8  -- 99 
 STV (range) 4.5 (1.8) 5.0 (2.8) 3.7 (1.9) -- 4.5 (2.0) 
 Low STV† 43 (55%) 6 (46%) 4 (50%)  53 (55%) 
 Decelerations (%) 26 (33%) 7 (54%) 3 (38%) -- 36 (37%) 
 Low STV† or/and 
decelerations 53 (68%) 11 (85%) 7 (88%) -- 71 (73%) 
 UA PI 2.0 (0.6) 2.8 (1.3) 2.6 (1.0) -- 2.2 (0.8) 
 U/C ratio * 1.6 (0.5) 2.0 (1.2) 2.0 (1.1) -- 1.7 (0.7) 
 UA ARED flow * 32 (41%) 8 (62%) 7 (88%) -- 47 (49%) 
DV PI N with last STV<24 hrs 172 13 15 5 205 
 STV (range) 4.6 (2.0) 4.5 (2.0) 5.1 (2.2) 4.9 (1.2) 46 (2.0) 
 Low STV† 70 (41%) 6 (46%) 4 (27%) 1 (20%) 81 (40%) 
 Decelerations (%) 69 (40%) 4 (31%) 5 (33%) 0 (--) 78 (38%) 
 Low STV† or/and 
decelerations 97 (56%) 9 (70%) 9 (60%) 1 (20%) 
116 
(57%) 
 UA PI 2.3 (0.9) 2.1 (0.8) 2.7 (1.4) 2.2 (0.9) 2.3 (0.9) 
 U/C ratio 1.8 (1.0) 1.9 (0.6) 2.0 (1.0) 1.8 (0.9) 1.8 (1.0) 
 UA ARED flow 104 
(60%) 10 (77%) 10 (67%) 2 (40%) 
126 
(62%) 
 N with last DVPI ≤3 days 152  14 14 7 187 
 DV PI 0.80 
(0.45) 
1.00 
(0.32) 
1.03 
(0.36) 
0.84 
(0.27) 
0.82 
(0.44) 
 DV PI > p95 * 50 (33%) 8 (57%) 9 (64%) 2 (29%) 69 (37%) 
 DV A wave abs/rev 12 (8%) 1 (7%) 1 (7%) 0 (--) 14 (8%) 
 DV PI >p95 + (Low STV† 
or/and decelerations) * 21 (14%) 4 (29%) 6 (43%) 0 (--) 31 (17%) 
 Recurrent DV PI >p95 > 1 
day before birth * 12 (8%) 4 (29%) 3 (14%) 1 (14%) 20 (11%) 
 DV PI > p95 once, later 
normal 4 (2%) 2 (14%) 0 (---) 0 (---) 6 (3%) 
 DV PI <p95 + (Low STV† 
or/and decelerations) 62 (41%) 5 (36%) 4 (29%) 1  (14%) 72 (39%) 
 DV PI <p95 + (Low STV‡ 
or/and decelerations) 54 (36%) 4 (29%) 3 (14%) 0 (--) 61 (33%) 
* P<0.05 
† STV cut-off by CTG-STV group criteria 
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‡ STV cut-off by DV groups safety-net criteria  
Abbreviations: CTG = cardiotocography; STV = short-term variation; DV = ductus venosus; 
UA = umbilical artery; PI = pulsatility index; AREDflow = absent/reversed end-diastolic flow; 
U/C-ratio = umbilical/cerebral ratio.  
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